دراسة فرط زيادة الانسولين بالدم والمتلازمة الايضية لدى مرضى داء السكري النوع الثاني == A Study Of Hyperinsulinemia And Metabolic Syndrome In Patients With Type 2 Diabetes
Author name:
علي عبد اللطيف حسن
Supervisor name:
THABIT NUMMAN WAHID AL | AZZAWE
General topic:
Medicine
Specific topic:
Clinical Biochemistry
Degree:
Master
University:
Mustansiriyah University - Faculty Of Medicine - Department Of Biochemistry
Language:
English
University location:
Baghdad
First pages:
19T1169 - p.pdf
Abstract:
مرض السكري من النوع الثاني هو اكثر اشكال مرض السكري شيوعا ويتميز باختلال افراز الانسولين واختلال فعاليته ويكون مصحوبا بمشكله زياده الممانعه للانسولين(وهي الحاله التي يكون فيها كميه الانسولين الطبيعيه تكون غير كافيه لانتاج نفس الفعاليه الايضيه في الخلايا | Type 2 diabetes is the most common form of diabetes and is characterized by disorders of insulin action and insulin secretion, and associated with increase problem of insulin resistant which is the condition in which normal amounts of insulin are inadequate to produce a normal insulin response from fat, muscle and liver cells. Insulin resistance in fat cells results in hydrolysis of stored triglycerides, which elevates free fatty acids in the blood plasma. Insulin resistance in muscle reduces glucose uptake, whereas insulin resistance in liver reduces glucose storage, with both effects serving to elevate blood glucose. High plasma levels of insulin and glucose due to insulin resistance often lead to metabolic syndrome.The combination of hypertension, dyslipidemia, insulin resistance, hyperinsulinemia, glucose intolerance, and obesity, particularly central obesity, has been termed the “metabolic syndrome.” It has been proposed that this syndrome is a powerful determinant of type 2 diabetes and cardiovascular disease.Material and measurements : The study is designed to measure BMI, FBS, TG, HDLc, and c - peptide and insulin level. history of hypertension, age of patients and duration of diabetes are Also taken in to account. These parameters and measures applied for forty five patients with diabetes and thirty normal as control subjects.Results : - There is a positive significant Correlation between insulin level of the diabetic patient and BMI - there is Also a positive significant correlation between insulin level and C - peptide in diabetic patient (r=0.781) (p=0.0001) and in healthy control (r=0.599) (p=0.0001). - There is a positive significant Correlation between C - peptide level of the diabetic patient and BMI - There is a significant negative correlation between HDL with HbA1c, in diabetic patient (r= - 0.423) (p=0.006) and significant correlation of HbA1c with FBS - There is a positive significant Correlation between duration of diabetes and age of the patient(r=0.783) (p=0.0001) - There is a significant negative correlation between C - peptide and duration of diabetes in diabetic patient (r= - 0.310) (p=0.045) - There is a significant correlation between TG with FBS values. - There is a negative significant correlation between TG with HDL values. - 37.8% of diabetic patients had metabolic syndrome and no one of the control subjects had the criteria of (WHO).Conclusion : There were large percentage of diabetic patients with different BMI had metabolic syndrome as compared with the control subjects. There were strong correlations between insulin level (hyperinsulinemia) and risk of metabolic syndrome development and appearance of its complications. The risk of hyperinsulinemia and metabolic syndrome was well correlated with BMI than with HbA1c. Most of over weight and obese patients had high insulin level with different degrees of glycemic control and duration of disease. Large number of patient with metabolic syndrome were hypertensive as compared with diabetic patients with out the syndrome.
